Patient Guide: Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06755450
Status: 🟢 Enrolling Now
Condition: Relapsed Advanced Lymphomas
Phase: PHASE1

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Vadodara, Gujarat
  • • Jhajjar, Haryana
  • • Bangalore, Karnataka
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma - Join Clinical Trial NCTNCT06755450

How to Join This Clinical Trial - NCTNCT06755450

Learn how to participate in this PHASE1 trial studying an investigational therapy for Relapsed Advanced Lymphomas. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Relapsed Advanced Lymphomas. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Relapsed Advanced Lymphomas
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06755450 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Vadodara, Gujarat 390001 - India

Status: RECRUITING

Clinical Research Site

Jhajjar, Haryana 124105 - India

Status: RECRUITING

Clinical Research Site

Bangalore, Karnataka 560027 - India

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Bangalore, Karnataka 560027 - India

Status: RECRUITING

Clinical Research Site

Aurangabad, Maharashtra 431001 - India

Status: RECRUITING

Clinical Research Site

Nagpur, Maharashtra 440026 - India

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Pune, Maharashtra 410014 - India

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Pune, Maharashtra 411014 - India

Status: RECRUITING

Clinical Research Site

Satara, Maharashtra 415519 - India

Status: RECRUITING

Clinical Research Site

Thāne, Maharashtra 400 615 - India

Status: ACTIVE_NOT_RECRUITING

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Relapsed Advanced Lymphomas:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships